New York, September 20, 2013 -- Moody's Investors Service said Gentiva Heath Services, Inc.'s (Gentiva) planned acquisition of key operations of Harden Healthcare Holdings, Inc. (Harden)for about $408.8 million does not immediately impact its B3 Corporate Family Rating given our expectation of only modest increase in the initial leverage and some strategic benefits from the acquisition. However, Moody's views the acquisition modestly credit negative, as Gentiva will need to integrate a fairly large acquisition at a time when both Gentiva and Harden's to be acquired operations are facing significant operating challenges.

Vollständigen Artikel bei Moodys lesen